Social networks
6,004Activities
Technologies
Entity types
Location
Rue Granbonpré 11, 1435 Mont-Saint-Guibert, Belgium
Mont-Saint-Guibert
Belgium
Employees
Scale: 11-50
Estimated: 54
Engaged corporates
4Added in Motherbase
1 year, 10 months agoNovadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
Novadip Biosciences is a clinical-stage biopharmaceutical company founded to design, develop, and bring to the market a new class of regenerative tissue products to accelerate healing of large bone defects and injuries in a single treatment. Novadip’s lead allogeneic product, NVD-X3, employs a matrix containing multiple bioactive factors that induce accelerated tissue healing. Designed as an “off-the-shelf” product, NVD-X3 can be shipped and stored at room temperature and offers superior intraoperative handling characteristics.
Novadip is also developing NVD-003, an autologous therapy derived from ASCs as a potential single treatment to save limbs and restore mobility in patients with congenital pseudarthrosis of the tibia (CPT). CPT is a rare pediatric bone condition.
Learn more about our technology platform and clinical development programs at www.novadip.com
Phone number: +32/10 77 92 20
E-mail: info@novadip.com
VAT: BE0535.575.602
Privacy policy: https://novadip.com/privacy-policy/
Regenerative Medicine, Stem cells, and Tissue Engineering
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Trends Kanaal Z Book and Periodical Publishing | Trends Kanaal Z Book and Periodical Publishing | Other 24 Mar 2024 | | |
Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 20 Dec 2023 | | |
SRIW Venture Capital and Private Equity Principals | SRIW Venture Capital and Private Equity Principals | Other 2 Oct 2022 | | |
Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 30 Jun 2022 | |